Prof. R. Roussel interviewed on diabetes and telemonitoring
Pr Roussel, head of the diabetology service at Bichat hospital in Paris, is the guest of the program “Sans Rendez-vous” hosted by Mélanie Gomez, the health specialist on Europe 1 French radio channel. He explains the risks for patients with diabetes facing COVID-19 and the need of telemonitoring to maintain the care of patients with diabetes and help manage their disease.
What are the risks for diabetic patients facing COVID-19?
According to the first Chinese and then European studies, diabetic patients are more exposed to the severe form of COVID- 19 infections. Professor Roussel notes that we do not yet have a definitive explanation for this situation. However, the first studies make it possible to better understand it. Thus, being overweight seems to be a risk factor. Patients with Type 2 diabetes are often overweight and they also have other problems like high blood pressure.
Glucose Control and COVID-19
The Diabetes disease has rapidly emerged as a major comorbidity for COVID-19 severity. However, the phenotypic characteristics of diabetes in COVID-19 patients are unknown. The CORONADO study, a French study is looking into describing the characteristics of diabetic patients who have been hospitalized for Covid-19. Initial results show that BMI, no long-term glucose control was positively and independently associated with getting infected with the virus. Nevertheless, Diabetes is a risk factor for poor prognosis in people with COVID-19.
Remote monitoring of patients
It has been very difficult for patients to get a follow-up with their doctor during the pandemic. Patients’ fear and closure of practices are 2 major factors. According to Professor Roussel, to “keep in touch” with your doctor is extremely important. In such a stressful time, it is crucial to better control diabetes by measuring blood sugar more frequently. Professor Roussel notes that remote monitoring is essential. He emphasizes the DIABNEXT solution, which combines a patient application and a secure platform for healthcare professionals. Providing access to patient data, the doctor can check the glycemic curves of his patients. If necessary, he can communicate with the patient via the application’s secure messaging or via the teleconsultation module. This is particularly reassuring for patients.
In addition, Professor Roussel indicates that in collaboration with Bichat Hospital Group, Lariboisière, and Cochin, the Covidiab application makes it possible to better help diabetic patients with symptoms.